300 top neuroscientists gathered to meet on and discuss a full range of CSF disorders affecting both children and adults, primarily focused on hydrocephalus.
lohud.com interviews Arthur Rappaport, the inventor of a portable real-time ultra-sound instrument that measures intracranial pressure without surgical intervention. The device is hoped to be a way to detect traumatic brain injury and treat pathological brain conditions.
March 10, 2014, marks the 50th anniversary of the recognition of NPH as a distinct medical condition, allowing countless people access to the treatment needed to return to active lifestyles after possibly years of living with misdiagnosed dementia. Join the Hydrocephalus Association as we commemorate this year.
The Hydrocephalus Association and the Rudi Schulte Research Institute (RSRI) announce a joint research venture with Dr. Mark Wagshul which proposes the use of magnetic resonance elastography (MRE) to determine the role brain compliance plays in pediatric hydrocephalus.
The Hydrocephalus Association aims to help our community understand the latest findings coming out of the hydrocephalus research community. In this blog, we summarize a study about Diffusion Tensor Imaging (DTI) and pediatric hydrocephalus.
An educational blog on the cranial nerves serving as a supplement to the Thrasher Research Fund’s study blog evaluating eye movement tracking for the detection of hydrocephalus posted by the Hydrocephalus Association.
As the Hydrocephalus Association continues its interview series in commemoration of their 30th anniversary, Dr. Harold L. Rekate, Director of the Chiari Institute in New York, sits down and shares a personal account of what inspired him to become a neurosurgeon, a career shaped by hydrocephalus and its patients, and his relationship with the Hydrocephalus Association.
Papilledema is an optic disc swelling that is secondary to elevated intracranial pressure around the brain associated with hydrocepahlus.The biggest concern with increased intracranial pressure is there is always the potential for visual loss secondary to the papilledema.